Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Healthcare appoints CR Bard distributor for Uriscreen

This article was originally published in Clinica

Executive Summary

Israeli diagnostics company Healthcare Technologies has appointed CR Bard as its exclusive distributor for the Uriscreen test kits in the US and Canada. Uriscreen was developed by Healthcare's subsidiary, Diatech Diagnostics, and is approved in the US and Japan as a first test for the detection of urinary diseases. Healthcare expects the deal to generate sales in excess of $2 million over the next three years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT092734

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel